INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 450m ago
HOUSE PTR49m ago
SEC 13F49m ago
ROBINHOOD CHAIN49m ago
SEC FORM 4/Grant or awardVerified data

Siegrist Jonathan Philip reported QDEL

EVP of R&D & CTO · QuidelOrtho Corp · Common Stock

Side
A
Value
—
Shares
2,448
Price
—
Executed
Jan 29, 2026
Disclosed
Feb 2, 2026
Disclosure timeline4 days from execution to publication · legal deadline 2 business days
Jan 29 executedFeb 2, 2026 disclosed

QDEL · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
17/ 100 · ROUTINE
Methodology →
  • Transaction type0 / 20

    Grant or award — administrative, little informational value

  • Relative size+9 / 25

No reported dollar value · 20.4% of prior position

  • Filing timing0 / 15

    Disclosed 2 business days after execution (deadline: 2)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · QDEL

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    21
    SP
    Siegrist Jonathan PhilipEVP of R&D & CTO
    QDELQuidelOrtho Corp
    Option exercise
    		M—
    18.7K sh
    		Oct 15, 2026Oct 19, 2026
    traded Oct 15, 2026
    		+4dSEC FORM 4

    Evidence

    9
    SP
    Siegrist Jonathan PhilipEVP of R&D & CTO
    QDELQuidelOrtho Corp
    Option exercise
    		M—
    18.7K sh
    		Oct 15, 2026Oct 19, 2026
    traded Oct 15, 2026
    		+4dSEC FORM 4

    Evidence

    20
    SP
    Siegrist Jonathan PhilipEVP of R&D & CTO
    QDELQuidelOrtho Corp
    Tax withholding
    		F$93K
    6,695 sh
    		Oct 15, 2026Oct 19, 2026
    traded Oct 15, 2026
    		+4dSEC FORM 4

    Evidence

    9
    BL
    Bowman Ronald LeeChief Human Resources Officer
    QDELQuidelOrtho Corp
    Option exercise
    		M—
    2,566 sh
    		Sep 15, 2026Sep 17, 2026
    traded Sep 15, 2026
    		+2dSEC FORM 4

    Evidence

    17
    BL
    Bowman Ronald LeeChief Human Resources Officer
    QDELQuidelOrtho Corp
    Tax withholding
    		F$9,790
    921 sh
    		Sep 15, 2026Sep 17, 2026
    traded Sep 15, 2026
    		+2dSEC FORM 4

    Evidence

    21
    BL
    Bowman Ronald LeeChief Human Resources Officer
    QDELQuidelOrtho Corp
    Option exercise
    		M—
    2,566 sh
    		Sep 15, 2026Sep 17, 2026
    traded Sep 15, 2026
    		+2dSEC FORM 4

    Evidence

    9
    HM
    Hanson Bryan MichaelEVP Global Port. Mgmt & Mkting
    QDELQuidelOrtho Corp
    Option exercise
    		M—
    446 sh
    		Aug 15, 2026Aug 18, 2026
    traded Aug 15, 2026
    		+3dSEC FORM 4

    Evidence

    13
    HM
    Hanson Bryan MichaelEVP Global Port. Mgmt & Mkting
    QDELQuidelOrtho Corp
    Option exercise
    		M—
    446 sh
    		Aug 15, 2026Aug 18, 2026
    traded Aug 15, 2026
    		+3dSEC FORM 4

    Evidence

    9
    HM
    Hanson Bryan MichaelEVP Global Port. Mgmt & Mkting
    QDELQuidelOrtho Corp
    Tax withholding
    		F$2,317
    162 sh
    		Aug 15, 2026Aug 18, 2026
    traded Aug 15, 2026
    		+3dSEC FORM 4

    Evidence

    21
    HM
    Hanson Bryan MichaelEVP Global Port. Mgmt & Mkting
    QDELQuidelOrtho Corp
    Option exercise
    		M—
    5,797 sh
    		Jul 1, 2026Jul 2, 2026
    traded Jul 1, 2026
    		+1dSEC FORM 4

    Evidence

    21
    HM
    Hanson Bryan MichaelEVP Global Port. Mgmt & Mkting
    QDELQuidelOrtho Corp
    Option exercise
    		M—
    5,797 sh
    		Jul 1, 2026Jul 2, 2026
    traded Jul 1, 2026
    		+1dSEC FORM 4

    Evidence

    17
    HM
    Hanson Bryan MichaelEVP Global Port. Mgmt & Mkting
    QDELQuidelOrtho Corp
    Tax withholding
    		F$38K
    2,096 sh
    		Jul 1, 2026Jul 2, 2026
    traded Jul 1, 2026
    		+1dSEC FORM 4

    Evidence

    5
    WD
    Wilkins Joseph D Jr.Director
    QDELQuidelOrtho Corp
    Grant or award
    		A—
    15.5K sh
    		Jun 25, 2026Jun 29, 2026
    traded Jun 25, 2026
    		+4dSEC FORM 4

    Evidence

    9
    MD
    McLellan Philip D.Chief Operations Officer
    QDELQuidelOrtho Corp
    Tax withholding
    		F$8,101
    699 sh
    		Apr 26, 2026Apr 28, 2026
    traded Apr 26, 2026
    		+2dSEC FORM 4

    Evidence

    17
    HM
    Hanson Bryan MichaelEVP Global Port. Mgmt & Mkting
    QDELQuidelOrtho Corp
    Grant or award
    		A—
    1,459 sh
    		Apr 26, 2026Apr 28, 2026
    traded Apr 26, 2026
    		+2dSEC FORM 4

    Evidence

    13
    HM
    Hanson Bryan MichaelEVP Global Port. Mgmt & Mkting
    QDELQuidelOrtho Corp
    Tax withholding
    		F$6,120
    528 sh
    		Apr 26, 2026Apr 28, 2026
    traded Apr 26, 2026
    		+2dSEC FORM 4

    Evidence

    9
    HM
    Hanson Bryan MichaelEVP Global Port. Mgmt & Mkting
    QDELQuidelOrtho Corp
    Option exercise
    		M—
    1,459 sh
    		Apr 26, 2026Apr 28, 2026
    traded Apr 26, 2026
    		+2dSEC FORM 4

    Evidence

    13
    MD
    McLellan Philip D.Chief Operations Officer
    QDELQuidelOrtho Corp
    Grant or award
    		A—
    1,946 sh
    		Apr 26, 2026Apr 28, 2026
    traded Apr 26, 2026
    		+2dSEC FORM 4

    Evidence

    9
    MD
    McLellan Philip D.Chief Operations Officer
    QDELQuidelOrtho Corp
    Option exercise
    		M—
    1,946 sh
    		Apr 26, 2026Apr 28, 2026
    traded Apr 26, 2026
    		+2dSEC FORM 4

    Evidence

    13
    MD
    McLellan Philip D.Chief Operations Officer
    QDELQuidelOrtho Corp
    Tax withholding
    		F$14K
    1,162 sh
    		Apr 22, 2026Apr 24, 2026
    traded Apr 22, 2026
    		+2dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0002040321-26-000002
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Jan 29, 2026
    Published
    Feb 2, 2026
    Ingested by INSIDER
    Nov 5, 04:19 UTC
    Last re-read
    Nov 5, 04:19 UTC

    Extracted facts

    Filer
    Siegrist Jonathan Philip
    Role
    EVP of R&D & CTO
    Transaction
    Grant or awardAs filed: “A”
    Asset
    QuidelOrtho Corp
    Ticker
    QDEL
    Shares
    2,448
    Price per share
    $0
    Execution date (reported)
    Jan 29, 2026
    Owned after transaction
    14.4K shares
    Days from execution to publication
    4

    What this establishes

    Siegrist Jonathan Philip filed this Form 4 reporting a grant or award of QDEL on Jan 29, 2026. It became public on Feb 2, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    EVP of R&D & CTO
    Siegrist Jonathan Philipcik:0002040321
    Issuer
    QuidelOrtho Corpcik:0001906324

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.